Found 1263 clinical trials
A Phase 3, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Atogepant For The Prevention Of Chronic Migraine (PROGRESS)
. Treatment groups include 30mg twice daily, 60mg once daily, and placebo. This study will consist of a 4-week screening and baseline period, a 12-week double-blind treatment period
- 358 views
- 03 Aug, 2020
- 1 location
Depression
the US population meets criteria for major depressive disorder over a 12-month period and women are 1.5-3 times as likely as men to develop MDD. Some treatments which have been
- 137 views
- 30 Jul, 2021
- 1 location
Birth Control Pill Study- Clinical Research Study of an investigational oral medication for Birth Control .
Birth Control Pill Study- Clinical Research Study of an investigational oral medication for Birth Control .
- 1372 views
- 08 Nov, 2020
- 1 location
A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis
A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis
- 278 views
- 08 Nov, 2020
- 1 location
A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis
A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis
- 186 views
- 08 Nov, 2020
- 1 location
Longitudinal Gait and Balance Measurement
Longitudinal Gait and Balance Measurement
- 268 views
- 23 Nov, 2020
- 1 location
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
- 644 views
- 08 Nov, 2020
- 1 location
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
- 271 views
- 23 Nov, 2020
- 1 location
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder
- 394 views
- 23 Nov, 2020
- 1 location
A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).
A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).
- 548 views
- 25 Mar, 2021
- 1 location